Peter Clemmensen-rekin lankidetzan egindako argitalpenak (2)

2021

  1. Lipoprotein(a) and Benefit of PCSK9 Inhibition in Patients With Nominally Controlled LDL Cholesterol

    Journal of the American College of Cardiology, Vol. 78, Núm. 5, pp. 421-433

2014

  1. Antiplatelet therapy. New potent P2Y12 inhibitors

    Pharmacological Treatment of Acute Coronary Syndromes (Springer London), pp. 31-57